Gene · 2072
Papers3,434
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 3,434
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Dissection of DNA damage and repair pathways in live cells by femtosecond laser microirradiation and free-electron modeling. | Proc Natl Acad Sci U S A | 2023 | 37307476 | PubTator, text mining | PubMed |
| The mechanism and clinical application of DNA damage repair inhibitors combined with immune checkpoint inhibitors in the treatment of urologic cancer. | Front Cell Dev Biol | 2023 | 37305685 | PubTator, text mining | PubMed |
| A genome-wide screen reveals that Dyrk1A kinase promotes nucleotide excision repair by preventing aberrant overexpression of cyclin D1 and p21. | J Biol Chem | 2023 | 37301510 | PubTator, text mining | PubMed |
| XPF-ERCC1 Blocker Improves the Therapeutic Efficacy of 5-FU- and Oxaliplatin-Based Chemoradiotherapy in Colorectal Cancer. | Cells | 2023 | 37296596 | PubTator, text mining | PubMed |
| The Effect of Final Irrigation Agitation Techniques on Postoperative Pain after Single Visit Root Canal Treatment of Symptomatic Irreversible Pulpitis: A Randomised Clinical Trial. | Eur Endod J | 2023 | 37257031 | PubTator, text mining | PubMed |
| Clinical considerations at the intersection of hematopoietic cell transplantation and hereditary hematopoietic malignancy. | Front Oncol | 2023 | 37251919 | PubTator, text mining | PubMed |
| The THO complex counteracts TERRA R-loop-mediated telomere fragility in telomerase+ cells and telomeric recombination in ALT+ cells. | Nucleic Acids Res | 2023 | 37246640 | PubTator, text mining | PubMed |
| Precision Medicine in Bladder Cancer: Present Challenges and Future Directions. | J Pers Med | 2023 | 37240925 | PubTator, text mining | PubMed |
| Brain Calcifications: Genetic, Molecular, and Clinical Aspects. | Int J Mol Sci | 2023 | 37240341 | PubTator, text mining | PubMed |
| Hereditary Cancer Syndromes: A Comprehensive Review with a Visual Tool. | Genes (Basel) | 2023 | 37239385 | PubTator, text mining | PubMed |
| Amelogenesis imperfecta: Next-generation sequencing sheds light on Witkop's classification. | Front Physiol | 2023 | 37228816 | PubTator, text mining | PubMed |
| Neddylation inhibition sensitises renal medullary carcinoma tumours to platinum chemotherapy. | Clin Transl Med | 2023 | 37226898 | PubTator, text mining | PubMed |
| MUS81 cleaves TOP1-derived lesions and other DNA-protein cross-links. | BMC Biol | 2023 | 37194054 | PubTator, text mining | PubMed |
| Molecular mechanisms protecting centromeres from self-sabotage and implications for cancer therapy. | NAR Cancer | 2023 | 37180029 | PubTator, text mining | PubMed |
| Role of the gut microbiota in anticancer therapy: from molecular mechanisms to clinical applications. | Signal Transduct Target Ther | 2023 | 37179402 | PubTator, text mining | PubMed |
| Dynamic conformational switching underlies TFIIH function in transcription and DNA repair and impacts genetic diseases. | Nat Commun | 2023 | 37179334 | PubTator, text mining | PubMed |
| Breaking the Mold: Epigenetics and Genomics Approaches Addressing Novel Treatments and Chemoresponse in TGCT Patients. | Int J Mol Sci | 2023 | 37175579 | PubTator, text mining | PubMed |
| Combination Chemotherapy with Selected Polyphenols in Preclinical and Clinical Studies-An Update Overview. | Molecules | 2023 | 37175156 | PubTator, text mining | PubMed |
| RNA-Sequencing Combined With Genome-Wide Allele-Specific Expression Patterning Identifies ZNF44 Variants as a Potential New Driver Gene for Pediatric Neuroblastoma. | Cancer Control | 2023 | 37161925 | PubTator, text mining | PubMed |
| Semi-supervised learning improves regulatory sequence prediction with unlabeled sequences. | BMC Bioinformatics | 2023 | 37147561 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2072/papers?page=14